Pricing Log in Create free account

Impact Biomedical Inc. (IBO) vs Tevogen Inc. (TVGN)

Impact Biomedical Inc. and Tevogen Inc. are both Biotechnology companies. Impact Biomedical Inc. and Tevogen Inc. are of similar size ($38.0M and $36.2M). Impact Biomedical Inc. has the higher net margin (2,254.3% vs 0.00%) and the lower return on invested capital (−22.8% vs 0.00%). Across the 12 metrics below, Tevogen Inc. leads on 7 and Impact Biomedical Inc. on 5.

Valuation

Metric IBO TVGN Biotechnology median
P/E n/m n/m 10.60
P/S 1,000.83 n/m 9.40
P/B 2.50 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 1,228.29 n/m 9.02
Earnings yield (27.13%) (115.91%) (32.88%)
Free cash flow yield (1.50%) (56.79%) (23.13%)

Profitability

Metric IBO TVGN Biotechnology median
Gross margin (1,111.43%) — 68.51%
Operating margin (14,600.00%) 0.00% 0.00%
Net margin 2,254.29% 0.00% 0.00%
Free cash flow margin (1,451.43%) 0.00% 0.00%
Return on equity 24.01% 123.10% (51.96%)
Return on assets 4.41% (492.20%) (46.06%)
Return on invested capital (22.81%) 0.00% 0.00%

Growth

Metric IBO TVGN Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 83.48% (130.86%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric IBO TVGN Biotechnology median
Debt to equity 0.00 (0.72) 0.00
Current ratio 0.16 0.33 4.97
Net debt to EBITDA 0.00 (0.15) 1.01

Dividend

Metric IBO TVGN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric IBO TVGN Biotechnology median
Market cap 38.01m 36.21m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack